NewYork-Presbyterian Morgan Stanley Children’s Hospital has been accredited under the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), a joint program of the American College of Surgeons and the American Society for Metabolic and Bariatric Surgery, in the treatment of pediatric bariatric surgical patients. NewYork-Presbyterian Morgan Stanley Children’s Hospital is the only stand-alone children’s hospital in New York State to hold this designation, accredited as an Adolescent Center, and one of only six in the nation.

Patients with acute myeloid leukemia (AML) may have genetic mutations in their blood indicating they are at high risk of developing the disease about nine years before diagnosis, according to research from Weill Cornell Medicine and NewYork-Presbyterian investigators. They presented their findings at the 59th annual American Society of Hematology meeting on Dec. 10 in Atlanta, Ga.

NewYork-Presbyterian and Walgreens are collaborating to bring convenient access to NewYork-Presbyterian’s world-class care through new telemedicine services, now available through Walgreens digital properties and at self-service kiosks at select Duane Reade drugstores in New York. NewYork-Presbyterian, New York’s No. 1 hospital, is offering the telemedicine services as part of its NYP OnDemand suite of digital health services.

Children from low-income neighborhoods had a higher mortality rate and higher hospital costs after heart surgery compared with those from higher-income neighborhoods, found a national study of more than 86,000 kids with congenital heart disease. The magnitude of the neighborhood effect, which persisted even after accounting for race, type of insurance, and hospital, was similar for children of all disease severities.

NewYork-Presbyterian has been recognized as one of the top 10 most innovative companies in artificial intelligence (AI) in the world by Fast Company. This selection is a part of Fast Company’s annual ranking of the world’s 50 Most Innovative Companies for 2018, which honors leading enterprises that exemplify the best in business and innovation. NewYork-Presbyterian, chosen for its use of AI and telemedicine, competed among thousands of companies surveyed by Fast Company editors and reporters to earn a spot on the prestigious list.

To expand access to life-saving liver transplants for those in need, NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine have unveiled a new living donor liver transplant program. It performed its first such transplant with success in late January.

Levetiracetam, the most commonly prescribed drug for U.S. infants with epilepsy, may be significantly more effective than the second-choice drug phenobarbital, according to a new study by scientists from Weill Cornell Medicine, NewYork-Presbyterian and 16 other research institutions. The findings provide the first evidence to favor levetiracetam in infants.